GlassScriptPhysician profile
Stephen Robert Shassberger
NPI 1639311640
$3,182.56
in general payments reported to CMS, 2019-2025
29 companies · $563 in 2025
The $563 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $58.83 · 2021: $253 · 2022: $456 · 2023: $1,592 · 2024: $150 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,282 · Food and Beverage: $947 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,282.38 |
| Food and Beverage | $947.41 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,390.96 | 2022-2023 | Interstim, Stealthstation S8 Platform |
| Astellas Pharma US INC | $301.56 | 2021-2025 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $148.27 | 2021-2022 | |
| Abbvie INC. | $147.98 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Sage Therapeutics, LLC | $142.08 | 2025 | Zurzuvae |
| Pfizer INC. | $126.54 | 2021-2024 | |
| Urovant Sciences INC | $109.53 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $95.91 | 2023-2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $71.31 | 2023-2025 | |
| Boston Scientific Corporation | $69.63 | 2025 | Solyx Sis System, Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous) |
| Exeltis, USA INC. | $63.65 | 2020-2025 | Slynd |
| Hologic Sales and Service, LLC | $56.39 | 2019-2025 | Acessa Provu System, Novasure |
| Shield Therapeutics INC | $53.53 | 2025 | |
| Amag Pharmaceuticals, INC. | $52.22 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $45.40 | 2025 | Qelbree |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $42.91 | 2022 | |
| Agile Therapeutics, INC. | $35.83 | 2021 | |
| Mayne Pharma Commercial LLC | $30.57 | 2022 | |
| Mylan Pharmaceuticals INC. | $25.14 | 2022 | |
| Exact Sciences Corporation | $23.13 | 2025 | The Cologuard Plus Collection Kit |
| Baxter Healthcare | $22.10 | 2022 | |
| Millicent US INC | $21.41 | 2025 | Intrarosa |
| Scynexis, INC. | $18.34 | 2022 | |
| Myovant Sciences INC. | $17.00 | 2022 | |
| Coopersurgical, INC. | $15.56 | 2025 | Paragard T 380a |
| Allergan, INC. | $15.36 | 2019 | |
| Novo Nordisk INC | $14.40 | 2019 | |
| Organon LLC | $13.11 | 2022 | |
| Olympus America INC. | $12.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Shassberger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.